Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 12 Mar 2025

Prediction of neoadjuvant chemotherapy efficacy and prognostic biomarker analysis in patients with triple-negative breast cancer

in Pharmacology of Anti-Cancer Drugs

Xiao-Wen Liao
Jia-Bin Gao
Hong Sun
Hong-Dan Chen
Min-Hui Zheng
Lei Han
Xiao-Geng Chen
Yu-Nan Su
Ding-Long Pan
Min Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1553831

1,052 views

Editorial

Published on 11 Mar 2025

Editorial: Metabolic reprogramming in cancer

in Pharmacology of Anti-Cancer Drugs

Valentina Audrito
Elisa Giovannetti

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1583986

820 views

Original Research

Published on 11 Mar 2025

Gut microbiota-derived metabolite phenylacetylglutamine inhibits the progression of prostate cancer by suppressing the Wnt/β-catenin signaling pathway

in Pharmacology of Anti-Cancer Drugs

Jing Lv
Shengkai Jin
Yuhua Zhou
Chaowei Fu
Yang Shen
Bo Liu
Jufa Li
Menglu Li
Yuwei Zhang
Ninghan Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1528058

1,575 views
1 citation

Original Research

Published on 11 Mar 2025

Adverse event profiles of EGFR-TKI: network meta-analysis and disproportionality analysis of the FAERS database

in Pharmacology of Anti-Cancer Drugs

Jing Shi
Xinya Liu
Mengjiao Gao
Jian Yu
Ting Chai
Yun Jiang
Jiawei Li
Yuanming Zhang
Li Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519849

2,090 views

Case Report

Published on 10 Mar 2025

Case Report: A novel MET exon 14 skipping mutation after EGFR-TKI resistance in advanced lung adenocarcinoma and sustained clinical response to savolitinib

in Pharmacology of Anti-Cancer Drugs

Yinyin Xue
Wen Li
Pengfei Li
Kaili Huang
Qinghua Zhou
Qiang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1489696

959 views

Review

Published on 10 Mar 2025

TCR-T cell therapy for solid tumors: challenges and emerging solutions

in Pharmacology of Anti-Cancer Drugs

Wanjun He
Kai Cui
Muhammad Asad Farooq
Na Huang
Songshan Zhu
Dan Jiang
Xiqian Zhang
Jian Chen
Yinxia Liu
Guangxian Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1493346

2,973 views
1 citation

Systematic Review

Published on 03 Mar 2025

Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcinoma: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Wenjun Quan
Hanifah Fazlin Zulkifli
Norhafizah Saari
Rafidah Hanim Shueb
Nazri Mustaffa

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1502931

1,746 views

Review

Published on 03 Mar 2025

The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases

in Pharmacology of Anti-Cancer Drugs

Weisong Zhang
Rui Wang
Rongqi Guo
Zhongquan Yi
Yihao Wang
Hao Wang
Yangyang Li
Xia Li
Jianxiang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538601

1,770 views

Original Research

Published on 03 Mar 2025

Multi-omics analysis of the dynamic role of STAR+ cells in regulating platinum-based chemotherapy responses and tumor microenvironment in serous ovarian carcinoma

in Pharmacology of Anti-Cancer Drugs

Hongwei Lan
Weihua Yan
Xiao Huang
Jiali Cui
Helei Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545762

1,598 views

Original Research

Published on 28 Feb 2025

Dehydrodiisoeugenol targets the PLK1-p53 axis to inhibit breast cancer cell cycle

in Pharmacology of Anti-Cancer Drugs

Lin Li
Yifan Zheng
Yongxia Yang
Senlin Shi
Shangjie Liu
Keying Huang
Luonan Qiu
Rongxin Zhang
Wenbin Huang
Yin Leng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545498

1,429 views

Mini Review

Published on 28 Feb 2025

Research progress on ferroptosis in Myelodysplastic syndromes

in Pharmacology of Anti-Cancer Drugs

Yifan Yang
Jiongping Han
Yuxin Wei
Jiacheng Jin
Weiyin Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561072

1,443 views

Original Research

Published on 28 Feb 2025

Repurposing hydrochlorothiazide (HCTZ) for colorectal cancer: a retrospective and single center study

in Pharmacology of Anti-Cancer Drugs

Dominic Chi-Chung Foo
Jiaxi Li
Zheng Huang
Siming Sui
Ryan Wai-Yan Sin
Abraham Tak Ka Man
Wai-Lun Law
Lui Ng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1449062

772 views

Original Research

Published on 26 Feb 2025

Small molecule inhibition of ubiquitin C-terminal hydrolase L1 alters cell metabolism proteins and exerts anti- or pro-tumorigenic effects contingent upon chemosensitivity status in high grade serous ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Corinne Jansen
Julia McAdams
Chloe Kim
Payton De La Cruz
Angelica Salaverria
Nicholas A. DaSilva
Kathryn Grive
Nicole E. James

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547164

1,060 views

Review

Published on 26 Feb 2025

Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives

in Pharmacology of Anti-Cancer Drugs

Xiaoya Li
Fang Yang
Meijing Wang
Xiaopeng Huang
Xin Zeng
Lu Zhou
Sixue Peng
Jingyi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1478331

3,408 views

Original Research

Published on 26 Feb 2025

Signal mining and analysis of ripretinib adverse events: a real-world pharmacovigilance analysis based on the FAERS database

in Pharmacology of Anti-Cancer Drugs

Ye Hu
Linlin Zhang
Qineng Gong
Lei Huang
Cunlin Yin
Yang Miao
Hui Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1481114

2,439 views

Review

Published on 26 Feb 2025

Mitochondria-associated non-coding RNAs and their impact on drug resistance

in Pharmacology of Anti-Cancer Drugs

Xingna An
Lina Sun
Huan Zheng
Yinghui Xiao
Weixia Sun
Dehai Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1472804

1,387 views
1 citation